Roche’s virtual event on key oncology data presented at ASCO 2021
Roche has hosted a virtual event on Tuesday, 8th June 2021.
| Agenda: | |
|---|---|
| Early pipeline programs in focus | William Pao, M.D., Ph.D.,Global Head of Roche Pharma Research and Early Development Ira Mellman, Ph.D., Vice President, Cancer Immunology, Genentech Research & Early Development |
| Late-stage pipeline programs in focus | Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development |
| ASCO 2021 Highlight | Tecentriq in adjuvant NSCLC: Phase 3 IMpower010 primary results Heather Wakelee, M.D., Prof. of Medicine, Stanford University Medical Center / Deputy Director Stanford Cancer Institute |
| Q&A | Please register to access the webcast* |